Fluticasone Furoate Slows Loss of Lung Function in COPD

This article originally appeared here.
Share this content:
Fluticasone Furoate Slows Loss of Lung Function in COPD
Fluticasone Furoate Slows Loss of Lung Function in COPD

FRIDAY, Aug. 4, 2017 (HealthDay News) -- Regular use of fluticasone furoate (FF), either alone or in combination with vilanterol (VI), appears to reduce the rate of forced expiratory volume in one second (FEV1) decline in patients with moderate chronic obstructive pulmonary disease (COPD) and a high risk of cardiovascular disease, according to a study published online July 24 in the American Journal of Respiratory and Critical Care Medicine.

Peter M.A. Calverley, M.B., Ch.B., from University of Liverpool in the United Kingdom, and colleagues conducted prespecified analysis of the key secondary outcome in the Study to Understand Mortality and MorbidITy (SUMMIT) to determine how inhaled corticosteroid FF (100 µg), the long-acting beta-agonist VI (25 µg), or the combination (FF/VI) modified the rate of decline in FEV1 versus placebo.

The researchers found that FF-containing regimes had lower rates of decline than placebo (P < 0.03), and FF/VI had lower rates of decline than VI alone (P < 0.005). The FEV1 decline was faster in current smokers, those with a lower body mass index, males, and patients with established cardiovascular disease.

"In patients with moderate COPD and heightened cardiovascular risk, FF alone or in combination with VI appears to reduce the rate of FEV1 decline," the authors write.

The study was funded by GlaxoSmithKline, which markets fluticasone furoate.

Abstract
Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Drug Lookup

Browse drugs by: BrandGenericDisease



Sign up for myCME e-newsletters




More in Home

Some California Mosquitoes Can Carry Zika Virus

Some California Mosquitoes Can Carry Zika Virus

Aedes aegypti mosquitoes found to transmit Zika virus

Periodontal Inflammation a Risk With Tongue Piercing

Periodontal Inflammation a Risk With Tongue Piercing

And, two young females with tongue piercings have deep lingual infrabony lesions, periodontitis

Risk of OD Highest for First Days of Opioid  Benzodiazepine Use

Risk of OD Highest for First Days of ...

Five-fold increased risk of opioid-related overdose during first 90 days of concurrent use

is free, fast, and customized just for you!




Already a member?

Sign In Now »